Cilnidipine versus Amlodipine Randomized Trial for Evaluation in Renal Desease
Not Applicable
- Conditions
- hypertensive patients with renal disease
- Registration Number
- JPRN-UMIN000000496
- Lead Sponsor
- niversity of Tokyo Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
1. Hypertensive emergency 2. Severe heart failure, severe arrhythmia, angina, myocardial infarction within 6 months of onset 3. Stroke within 6 months of onset 4. Severe diabetes mellitus 5. Prengnancy and possible pregnancy 6. History of severe side effect of calcium channel blocker, ARB, or ACE inhibitor 7. Patients who are treateing with cilnidipine or amlodipine 8. Patinets who are inadequate to entry this study by physicians in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rinary protein as protein/creatinine ratio
- Secondary Outcome Measures
Name Time Method Cardiovascular death Cardiovascular event